Bariatric Surgery Survey 2018: Similarities and Disparities Among the 5 IFSO Chapters
- PMID: 33432483
- PMCID: PMC7800839
- DOI: 10.1007/s11695-020-05207-7
Bariatric Surgery Survey 2018: Similarities and Disparities Among the 5 IFSO Chapters
Abstract
Background: The 2018 IFSO Survey focused on similarities and disparities in the number and types of surgical and endoluminal interventions among the IFSO chapters occurred in the last decade.
Methods: All IFSO Societies were asked to fill in the IFSO survey form on how many and which surgical and endoluminal interventions have been performed in the 2018. A special section was added, asking about the existence of national guidelines for bariatric and metabolic surgery, national recommendations for preoperative gastroscopy, type of reimbursement for bariatric/metabolic surgery, including for patients with BMI < 35 kg/m2. The trend analyses from 2008 to 2018 were also performed.
Results: Fifty-seven/65 (87.7%) IFSO Societies submitted completed forms. The American Society for Metabolic and Bariatric Surgery did not fill the IFSO survey form but provided an official report on the performed interventions. The total number of surgical and endoluminal procedures performed in 2018 in the world was 696,191. Sleeve gastrectomy (SG) remained the most commonly performed bariatric procedure (N = 386,096; 55.4%). Among the total reported bariatric/metabolic interventions, 604,223 (86.8%) were primary surgical and 29,167 (4.2%) primary endoluminal operations; 62,801 (9%) were revisional procedures.
Conclusions: There was only a slight increase (10.317 procedures) in the total number of the reported bariatric interventions compared to the last IFSO survey. SG continues to be the most commonly performed operation since 2014. The one anastomosis gastric bypass (OAGB), currently the third most performed procedure after SG and Roux-en-Y gastric bypass (RYGB), continues to rise in popularity worldwide.
Keywords: IFSO Chapters; IFSO Survey; Metabolic and Bariatric Surgery.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Figures
Similar articles
-
IFSO Worldwide Survey 2020-2021: Current Trends for Bariatric and Metabolic Procedures.Obes Surg. 2024 Mar 4. doi: 10.1007/s11695-024-07118-3. Online ahead of print. Obes Surg. 2024. PMID: 38438667
-
IFSO Worldwide Survey 2016: Primary, Endoluminal, and Revisional Procedures.Obes Surg. 2018 Dec;28(12):3783-3794. doi: 10.1007/s11695-018-3450-2. Obes Surg. 2018. PMID: 30121858
-
Bariatric Surgery and Endoluminal Procedures: IFSO Worldwide Survey 2014.Obes Surg. 2017 Sep;27(9):2279-2289. doi: 10.1007/s11695-017-2666-x. Obes Surg. 2017. PMID: 28405878 Free PMC article.
-
IFSO Update Position Statement on One Anastomosis Gastric Bypass (OAGB).Obes Surg. 2021 Jul;31(7):3251-3278. doi: 10.1007/s11695-021-05413-x. Epub 2021 May 3. Obes Surg. 2021. PMID: 33939059 Review.
-
Revisional Roux-en-Y Gastric Bypass and Sleeve Gastrectomy: a Systematic Review of Comparative Outcomes with Respective Primary Procedures.Obes Surg. 2015 Jul;25(7):1271-80. doi: 10.1007/s11695-015-1670-2. Obes Surg. 2015. PMID: 25893649 Review.
Cited by
-
Identification of circulating apolipoprotein M as a new determinant of insulin sensitivity and relationship with adiponectin.Int J Obes (Lond). 2024 Mar 15. doi: 10.1038/s41366-024-01510-w. Online ahead of print. Int J Obes (Lond). 2024. PMID: 38491190
-
Indications and Coverage of Metabolic and Bariatric Surgery: A Worldwide IFSO Survey Comparing Different National Guidelines.Obes Surg. 2024 Mar 13. doi: 10.1007/s11695-024-07142-3. Online ahead of print. Obes Surg. 2024. PMID: 38472706
-
Outcomes of primary versus conversional Roux-En-Y gastric bypass after laparoscopic sleeve gastrectomy: a retrospective propensity score-matched cohort study.BMC Surg. 2024 Mar 6;24(1):84. doi: 10.1186/s12893-024-02374-7. BMC Surg. 2024. PMID: 38448841 Free PMC article.
-
IFSO Worldwide Survey 2020-2021: Current Trends for Bariatric and Metabolic Procedures.Obes Surg. 2024 Mar 4. doi: 10.1007/s11695-024-07118-3. Online ahead of print. Obes Surg. 2024. PMID: 38438667
-
Impact of bariatric surgery on oral anticancer drugs: an analysis of real-world data.Cancer Chemother Pharmacol. 2024 Mar 1. doi: 10.1007/s00280-024-04640-0. Online ahead of print. Cancer Chemother Pharmacol. 2024. PMID: 38427065
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
